PCP vs Telehealth for GLP-1: Pros, Cons, and How to Choose

Many of you have an existing relationship with a primary care provider and are wondering whether to bring your GLP-1 question there or turn to a telehealth service. Others have no PCP at all (about 30 million Americans are uninsured or underserved)^[1]. The answer is not one-size-fits-all. It depends on whether you have insurance, how quickly you want to start, whether you already have an established relationship with a provider, and what your specific health situation looks like.

This page compares the two paths honestly. We’ll look at real pros and cons, walk through the timeline and cost differences, and help you figure out which route makes sense for your situation.

The Primary Care Path: Honest Pros

You have an established health history. Your PCP knows your medical past, other medications you take, chronic conditions, family history. That context matters when starting a new medication. If you have multiple health issues that need management alongside your weight, your PCP can handle all of it in one relationship.

Insurance integration, if available. If you have insurance that covers GLP-1 medications, your PCP can work within that system. They can submit claims, navigate prior authorization (though this adds time), and help troubleshoot if the insurance company questions the prescription.

In-person evaluation. An in-person appointment allows your PCP to do a physical exam, take vital signs, and pick up on things a telehealth intake form cannot. That’s a real clinical advantage.

Trust and continuity. Some patients prefer face-to-face relationships with their providers. If that’s you, and your PCP is responsive, staying in that relationship has real value.

The Primary Care Path: Honest Cons

Wait times can be long. Getting a new patient appointment or a dedicated weight management discussion with your PCP often takes 2-8 weeks or longer, depending on your clinic’s schedule. If you already see them regularly, you might get in sooner, but don’t count on it.

Variable familiarity with GLP-1. Many PCPs are comfortable prescribing GLP-1 for type 2 diabetes, where the indication is clearer. For weight management in metabolically healthy patients, or in patients new to GLP-1, comfort levels vary significantly. Your PCP may not have deep experience with the escalation schedules, side effect management, or monitoring protocols specific to GLP-1 weight management.

Limited appointment time. A typical PCP visit is 15-20 minutes. That’s not enough time to deeply explore the GLP-1 decision, understand your goals, cover the dosing protocol, discuss lifestyle expectations, and address all your questions. GLP-1 treatment requires patient education that a standard office visit cannot always deliver.

Prior authorization delays. If your insurance covers GLP-1 but requires prior authorization, you’re looking at another 4-8+ weeks of waiting, and there is no guarantee of approval. Many insurers deny these requests or require failed attempts at other treatments first. During this time, you’re waiting, not starting.

Minimal ongoing monitoring. Most primary care offices do not provide structured medical weight loss coaching or the level of ongoing touchpoints that a dedicated weight management service does. A follow-up might happen once every 3-6 months, not every month or every two weeks.

Lab costs are separate. If labs are ordered through your PCP’s office, they typically go through insurance billing, which means copays and deductibles on top of what you’re already paying. There is no bundling.

The Telehealth Weight Management Path: Honest Pros

Speed. You complete the intake today. A provider reviews your information and makes a decision within 24-48 hours. If prescribed, your medication is prepared by a licensed compounding pharmacy and shipped to your door within 7-14 days. Total time from first contact to medication in hand: roughly 10-20 days instead of 12-16+ weeks.

Specialization. Telehealth weight management platforms are built for this specific use case. The providers are reviewing GLP-1 cases every single day. They have deep experience with dosing, side effect management, escalation protocols, and the lifestyle coaching that makes the medication actually work.

All-inclusive pricing. Your monthly fee covers the medication, baseline labs, ongoing labs, and dedicated medical weight loss coaching. There are no surprise bills, no separate copays per service, no insurance billing surprises. You know exactly what you’re paying.

No insurance required. This matters if you are uninsured, underinsured, or your insurance doesn’t cover weight management GLP-1. You pay one flat fee; there is no prior authorization, no denials, no waiting for insurance approval.

Structured coaching is built in. Medical weight loss coaching (nutrition guidance, habit-building, accountability) is part of the program, not an add-on or something you have to hunt for. This is a major differentiator from a PCP model.

Geographic reach. If you live in a rural area or somewhere with limited PCP availability, telehealth gives you access to licensed providers regardless of location. Currently available in all 50 states and DC.

The Telehealth Weight Management Path: Honest Cons

No physical exam. The intake relies on self-reported information and lab results. A telehealth provider cannot check your vital signs, listen to your heart, or find incidental findings a physical exam might catch. For most patients pursuing GLP-1 weight management who are otherwise relatively healthy, this is not a barrier. Patients with complex comorbidities should consider whether an in-person specialist evaluation would be safer.

No continuity with broader care. Your telehealth provider focuses on the GLP-1 program. They are not your PCP. They cannot manage your diabetes, hypertension, or other chronic conditions. If you need that broader coordination, you still need a PCP.

Compounded medications are not FDA-approved. This is the big one. Telehealth services using compounded GLP-1 medications are prescribing drugs that have not been independently evaluated by the FDA for safety, efficacy, or quality. The active ingredient (semaglutide or tirzepatide) has been studied in FDA-approved branded medications. Compounded versions are different products and have not undergone the same review. This is a meaningful distinction, and you should understand it fully.

Not ideal for complex medical situations. If you have multiple comorbidities, are on many other medications, or have unusual medical complexity, you may be better served by in-person specialist care where the provider can coordinate across your full health picture.

Side-by-Side Comparison

Who Should Choose Which Path

Choose your PCP first if:

• You have insurance that covers GLP-1 weight management and you want to use it
• You have complex medical comorbidities that need coordination with your broader care
• You prefer in-person evaluation and an existing provider relationship
• You are already scheduled with your PCP soon and want to bring it up in that visit
• You have tried the telehealth route and want a second opinion from your personal provider

Choose telehealth if:

• You have no insurance or insurance that doesn’t cover weight management GLP-1
• You want to start within weeks, not months
• You live in a rural or underserved area with limited PCP availability
• You have already tried bringing this up with a PCP and didn’t get what you needed
• You want the all-inclusive bundled model with no surprise billing
• You value ongoing structured coaching as part of your program

The Continuity-of-Care Question

One legitimate concern that has emerged in the medical community is whether telehealth-only GLP-1 prescribing, without integration into a patient’s broader medical care, creates gaps in monitoring and oversight. This is worth addressing directly because both PCPs and patients have raised real questions.

What PCPs and Medical Organizations Are Saying

A 2024 survey conducted by Omada Health in partnership with Sermo found that two-thirds of primary care providers (67%) expressed concern about the health risks if their patients access GLP-1 prescriptions through third-party telehealth companies without a prior relationship^[2]. The top specific concerns cited were:

• Overprescribing (56%): Clinically inappropriate prescriptions to patients who may not meet medical criteria or who have contraindications that a full health history review would catch.
• Continuity of care (50%): Lack of structured follow-up, dose titration oversight, medication tapering, and integration with the patient’s existing medical history and other medications.

Beyond the survey data, some medical organizations have expressed caution about “siloed” GLP-1 prescribing without access to a patient’s complete medical picture.

The Real Risks

The continuity-of-care concern centers on a few specific clinical scenarios:

1. Missing contraindications: If a telehealth provider reviews only the intake form but does not have access to a patient’s full medical records, they might miss a subtle contraindication (like a history of pancreatitis or thyroid nodules) that a PCP reviewing the complete chart would catch.

2. Drug interactions: If a patient is on multiple medications managed by different providers, GLP-1 interactions with those drugs might go unnoticed without coordinated medical oversight.

3. Dose escalation decisions: GLP-1 medications require careful escalation. If a patient experiences side effects or a plateau in weight loss, the decision to increase the dose should be based on a complete clinical picture, not just the patient’s self-report.

4. Medication deprescribing: At some point, patients may want to reduce or stop the medication. This should be done under medical supervision to avoid rebound weight gain or other complications. Telehealth-only models may not provide the structured deprescribing support.

How Reputable Telehealth Programs Address These Gaps

Legitimate GLP-1 telehealth services have built-in safeguards to address the continuity-of-care concern:

• Comprehensive intake questionnaire: More than just basic demographics. Detailed health history, current medications, surgeries, allergies, and contraindication screening.
• Lab review before starting: Baseline labs are required before any prescription is written. These labs help identify otherwise-undetected issues (kidney disease, thyroid nodules, metabolic abnormalities) that might contraindicate the medication.
• Mandatory labs at monitoring intervals: Most programs require repeat labs at 3 months, 6 months, and annually to track kidney function, liver function, and metabolic markers. These labs create checkpoints.
• Asynchronous provider messaging: Patients can message their provider between visits with questions or concerns. The provider can adjust dosing, address side effects, or escalate to a real-time visit if needed.
• Dose escalation only after provider review: The provider reviews labs and patient feedback before approving any dose increase. Escalation is not automatic.

Transformation Health incorporates all of these elements. Every patient receives individual provider review, baseline labs before prescription, and monthly coaching touchpoints with structured lab monitoring.

What Patients Should Do

If you choose telehealth for your GLP-1 program, here are specific steps to maintain good continuity of care:

1. Share your telehealth records with your PCP: Request a copy of your intake assessment and lab results from the telehealth provider and send them to your PCP. This closes the information gap.

2. Bring your complete medication list to all appointments: Whether with your PCP or telehealth provider, make sure they have a current list of everything you are taking. Note the GLP-1 medication prominently.

3. Inform your PCP before any surgery or procedure: GLP-1 medications slow digestion, which creates a gastroparesis risk under anesthesia. Your anesthesiologist and surgeon need to know you are on the medication before any procedure.

4. Use the provider messaging feature: If you experience side effects or have concerns between scheduled monitoring, message your telehealth provider rather than waiting. Do not manage escalation decisions on your own.

5. Keep up with scheduled labs: Labs are not optional. They are how the provider monitors for kidney function decline, metabolic changes, or other complications. Missing scheduled labs creates the very continuity gap that PCPs worry about.

Can You Use Both?

Yes. These paths are not mutually exclusive. Some patients use a telehealth service for their GLP-1 program while maintaining their PCP relationship for overall health management. The telehealth provider handles the GLP-1 protocol and coaching. Your PCP handles everything else. It is worth informing your PCP that you are on a GLP-1 medication so they can factor it into any other medications or conditions they are managing.

The key is clear communication between your providers so everyone understands who is responsible for what.

What a Legitimate Telehealth Service Looks Like

If you choose the telehealth route, here is what to look for:

• Independent, licensed providers reviewing each patient’s intake individually (not automated approval)
• Required baseline labs before any prescription decision
• Clear, upfront disclosure that compounded medications are not FDA-approved
• Cancel anytime with no penalties or commitments
• All-inclusive pricing with no hidden fees
• Monthly coaching touchpoints and structured follow-up
• Clear identification of the compounding pharmacy preparing your medication

Transformation Health meets these standards. Every patient receives individual provider review, required baseline labs, all-inclusive pricing with no surprises, and ongoing monthly coaching. Medications are prepared by US-licensed compounding pharmacies.

Citations

[1] U.S. Census Bureau. “Health Insurance Coverage.” American Community Survey. https://www.census.gov/

[2] Omada Health and Sermo. “Doctors Report Concerns about Overprescribing and Continuity of Care with Patient Access to GLP-1 Medications through Third-Party Telehealth Prescribers.” Survey Report, January 2024. https://resourcecenter.omadahealth.com/for-employers/doctors-report-concerns-about-overprescribing-and-continuity-of-care-with-patient-access-to-glp-1-medications-through-third-party-telehealth